Scientists probe Aging's effect on key enzymes in blood and colon
NCT ID NCT06132386
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how aging changes certain enzymes (proteins) in the blood and colon. Researchers collected blood and colon tissue samples from 21 healthy adults, both younger (18-50) and older (65-80). They also checked if the HIV medications tenofovir and emtricitabine affect these enzymes. The goal was to better understand aging and drug interactions, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins University
Baltimore, Maryland, 21287, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Nicotine gum may restore aging hearing — a Brain-Scan trial puts it to the test
- Calf power may hold the key to healthy aging – a study investigates
- Peer-led prevention: can gancheros help stop HIV, hepatitis c, and overdose in NYC?
- Small cash rewards may keep HIV-positive mothers in treatment — a trial puts the idea to the test
- Centenarians put to the test: can exercise reverse frailty at age 100?
- Can a gentle leg workout with blood flow restriction spare the nervous system?